What Can Tinnitus Research Teach Us About Future Treatments?

When people live with tinnitus, the immediate priority is often relief: sleeping better, feeling calmer, concentrating again, and regaining a sense of normal life. But alongside this important work, there is also a wider scientific effort to better understand the condition itself and explore what future treatments may become possible.

Drawing on an Aristotelian distinction between responding to immediate needs and striving towards longer-term human flourishing, Dr Hashir Aazh reflects on why coping-based therapies remain essential for people living with tinnitus, while scientific research continues the longer-term search for deeper biological understanding and future treatments.

At the 2nd International Conference on Pharmacology and Gene Therapy for Tinnitus, researchers, clinicians, and neuroscientists from different countries came together to discuss one important question: why is tinnitus so difficult to treat?

The conference was not about announcing a cure. Instead, it highlighted how tinnitus is far more complex than many people realise, and why understanding that complexity matters for future treatments.

For many years, tinnitus was mainly viewed as a problem of the ear. However, discussions throughout the conference reinforced a growing scientific view that tinnitus involves not only the auditory system, but also brain networks linked to attention, stress, emotion, memory, and perception.

One major theme was the idea that tinnitus may develop when the brain tries to compensate for reduced hearing input. When hearing is damaged, such as after noise exposure or hearing loss, the auditory system may increase its sensitivity, almost like turning up the volume on a weak radio signal. Researchers believe this increased sensitivity may allow internal neural activity to become consciously perceived as tinnitus.

Speakers also discussed how the balance between calming and activating signals in the brain may become disrupted. Normally, the brain carefully regulates neural activity. But after acoustic trauma or other changes, some hearing pathways may become overactive or poorly regulated. Several presentations explored how this imbalance could contribute to tinnitus and sound sensitivity.

Another important reflection from the conference was that tinnitus is probably not one single condition. Two people may both describe ringing in the ears, but the underlying biological mechanisms may be very different. In some individuals, hearing loss may play the dominant role. In others, stress, emotional processing, or sound sensitivity may contribute more strongly.

This may help explain why tinnitus treatments often produce mixed results. A treatment that works for one subgroup of patients may not work for another. Because of this, many researchers argued that the future of tinnitus care will likely involve more personalised and stratified approaches rather than a single universal treatment.

The conference also highlighted both the promise and limitations of pharmacological research. Scientists are identifying potential targets involving neurotransmitters, neural excitability, and auditory processing pathways. However, translating laboratory findings into real-world treatments remains difficult because tinnitus is ultimately a subjective experience. Unlike blood pressure or hearing thresholds, tinnitus cannot yet be directly measured with a single objective test.

Importantly, the meeting reinforced that pharmacological and psychological approaches should not be viewed as opposing models. Behavioural approaches such as cognitive behavioural therapy (CBT) may help change how tinnitus is interpreted and responded to, while pharmacological approaches may eventually help modify the underlying neural activity itself. Many researchers now see these approaches as complementary rather than competing.

The discussions from the conference will continue at the 4th World Tinnitus Congress and 15th International Tinnitus Seminar in London in 2027, organised in partnership with Tinnitus UK, British Academy of Audiology, British Society of Audiology, ENT UK, American Auditory Society, American Academy of Audiology, Audiology Practice Standards Organisation, Misophonia Research Fund, University of California Center for Hearing Research, British Association for Behavioural and Cognitive Psychotherapies, Institute of Sensory Organs, International Society of Audiology, RNID, British Society of Hearing Aid Audiologists, Association of Independent Hearing Healthcare Professionals, European Federation of Audiology Societies, and International Federation of Otorhinolaryngological Societies. The event will bring together researchers, clinicians, psychologists, ENT specialists, audiologists, hearing scientists, and patient organisations from around the world to further explore the future of tinnitus research and care.

Dr Hashir Aazh is Director of the Hashir International Institute in London and President of the 4th World Tinnitus Congress and 15th International Tinnitus Seminar. Specialising in the assessment and management of tinnitus and hyperacusis, Dr Aazh is an advocate for both improving access to tinnitus care and supporting research aimed at better understanding and silencing tinnitus.